Gyre Therapeutics, Inc. (GYRE)
(Real Time Quote from BATS)
$7.69 USD
+0.17 (2.26%)
Updated Oct 3, 2025 11:14 AM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GYRE 7.69 +0.17(2.26%)
Will GYRE be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for GYRE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GYRE
Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates
Prothena (PRTA) Reports Q2 Loss, Lags Revenue Estimates
GYRE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates
Blueprint Medicines (BPMC) Reports Q1 Loss, Lags Revenue Estimates
Other News for GYRE
Is GYRE heading for a slide? 20 Day Moving Average Resistance shows up after sinking 0.79%
20 Day Moving Average Resistance appears for GYRE after 1.61% move
The technical outlook for GYRE is unchanged after it falls 0.53% on September 30
GYRE forms Stochastic Buy Signal on September 30
Technical picture remains unchanged for GYRE after it falls 1.78% on September 27